Rn. Alyaudtin et al., Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brainbarrier in vivo and in vitro, J DRUG TAR, 9(3), 2001, pp. 209
Poly(butylcyanoacrylate) nanoparticles were produced by emulsion polymerisa
tion and used either uncoated or overcoated with polysorbate 80 (Tween (R)
80). [H-3]-dalargin bound to nanoparticles overcoated with polysorbate 80 o
r in the form of saline solution was injected into mice and the brain conce
ntrations of radioactivity determined. Statistically significant, three-fol
d higher brain concentrations with the nanoparticle preparations were obtai
ned after 45 minutes, the time of greatest pharmacological response assesse
d as analgesia in previous experiments. In addition the brain inulin spaces
in rats and the uptake of fluoresceine isothio-cyanate labelled nanopartic
les in immortalised rat cerebral endothelial cells, (RBE4) were measured. T
he inulin spaces after i.v. injection of polysorbate 80-coated nanoparticle
s were significantly increased by 1% compared to controls. This is interpre
ted as indicating that there is no large scale opening of the tight junctio
ns of the brain endothelium by the polysorbate 80-coated nanoparticles. In
in vitro experiments endocytic uptake of fluorescent nanoparticles by RBE4
cells was only observed after polysorbate 80-overcoating, not with uncoated
particles. These results further support the hypothesis that the mechanism
of blood-brain barrier transport of drugs by polysorbate 80-coated nanopar
ticles is one of endocytosis followed by possible transcytosis. The experim
ents were conducted in several laboratories as part of an EEC/INTAS collabo
rative program. For various procedural and regulatory reasons this necessit
ated the use of both rats and mice as experimental animals. The brain endot
helial cell line used for the in vitro studies is the rat RBE4.